Sanofi, GSK to seek approval for Covid vaccine candidate that prevents 100% of hospitalizations
The logo of Sanofi is seen at the company's research and production centre in Vitry-sur-Seine, France, August 6, 2019.
French drugmaker Sanofi and its British partner GlaxoSmithKline are seeking regulatory approval for their Covid-19 vaccine to be used as a booster, as well as a standalone two-dose shot, after several setbacks.
The companies said on Wednesday they intended to submit data to regulators from a late-stage trial of the vaccine, and another testing it as a booster, with full results for both studies expected to be published "later this year."
Sanofi is hoping for a comeback after falling behind in the race for Covid-19 shots, while GSK, the world's biggest vaccine maker by sales, has not developed its own candidate and is instead supplying its adjuvant technology to develope...









